sefulness of contrast enhanced three-dimensional ultrasonography in assessing treatment effects.

Not Applicable

Recruiting

• Conditions: iver neoplasm

• Registration Number: JPRN-UMIN000003292
• Lead Sponsor: Tokyo Metropolitan Cancer and Infectious diseases Center Komagome Hospital

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Study Start: 2010-03-05
• Last Update Posted: 17 October 2023

Recruitment & Eligibility

• Status: Recruiting
• Sex: All
• Target Recruitment: 300

Inclusion Criteria

Not provided

Exclusion Criteria

Allergy for egg

Study & Design

• Study Type: Interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
The ability of assessing treatment effects.